These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6685059)

  • 1. Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator.
    Bányai L; Váradi A; Patthy L
    FEBS Lett; 1983 Oct; 163(1):37-41. PubMed ID: 6685059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes.
    Lee SG; Kalyan N; Wilhelm J; Hum WT; Rappaport R; Cheng SM; Dheer S; Urbano C; Hartzell RW; Ronchetti-Blume M
    J Biol Chem; 1988 Feb; 263(6):2917-24. PubMed ID: 3125172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM; Dewerchin M; Lijnen HR; Bernar H; Bulens F; Nelles L; Collen D
    Eur J Biochem; 1992 Apr; 205(1):139-46. PubMed ID: 1313361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a recombinant chimeric plasminogen activator with enhanced fibrin binding.
    Jiao J; Yu M; Ru B
    Biochim Biophys Acta; 2001 Apr; 1546(2):399-405. PubMed ID: 11295444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
    Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kringles: modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases.
    Patthy L; Trexler M; Váli Z; Bányai L; Váradi A
    FEBS Lett; 1984 Jun; 171(1):131-6. PubMed ID: 6373375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production in eukaryotic cells and characterization of four hybrids of tissue-type and urokinase-type plasminogen activators.
    Piérard L; García Quintana L; Reff ME; Bollen A
    DNA; 1989 Jun; 8(5):321-8. PubMed ID: 2504571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
    Beckmann R; Geiger M; de Vries C; Pannekoek H; Binder BR
    J Biol Chem; 1991 Feb; 266(4):2227-32. PubMed ID: 1824940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.
    Kasai S; Arimura H; Nishida M; Suyama T
    J Biol Chem; 1985 Oct; 260(22):12377-81. PubMed ID: 3930494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid molecules: insights into plasminogen activator function.
    Runge MS; Bode C; Haber E; Quertermous T
    Mol Biol Med; 1991 Apr; 8(2):245-55. PubMed ID: 1806766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of human plasma and extracellular matrix fibronectin by tissue type plasminogen activator and urokinase.
    Marchina E; Barlati S
    Int J Biochem Cell Biol; 1996 Oct; 28(10):1141-50. PubMed ID: 8930138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression in E. coli of finger-domain lacking tissue-type plasminogen activator with high fibrin affinity.
    Kagitani H; Tagawa M; Hatanaka K; Ikari T; Saito A; Bando H; Okada K; Matsuo O
    FEBS Lett; 1985 Sep; 189(1):145-9. PubMed ID: 3896853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.
    Sato J; Schorey J; Ploplis VA; Haalboom E; Krahule L; Castellino FJ
    Am J Pathol; 2003 Aug; 163(2):517-31. PubMed ID: 12875972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.
    Holvoet P; Laroche Y; Lijnen HR; Van Hoef B; Brouwers E; De Cock F; Lauwereys M; Gansemans Y; Collen D
    Eur J Biochem; 1992 Dec; 210(3):945-52. PubMed ID: 1483477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomous functions of structural domains on human tissue-type plasminogen activator.
    van Zonneveld AJ; Veerman H; Pannekoek H
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4670-4. PubMed ID: 3088564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolysis using tissue-type plasminogen activator and pro-urokinase: synergism; mutants and hybrids].
    Páramo JA; Fernández FJ; Cuesta B; Paloma MJ; Rocha E
    Sangre (Barc); 1989 Aug; 34(4):297-9. PubMed ID: 2505395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.